Clinical Trial Update: Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MitoQ for raised liver enzymes due to chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MitoQ

Snippet

Sponsor: Antipodean Pharmaceuticals, Inc. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED